You are viewing: Australia Remote Patient Monitoring (RPM) Market analysis

The Australia Remote Patient Monitoring (RPM) Market was valued at $404.8 Million in 2026 and projected to reach to $816.1 Million by 2031, representing a compound annual growth rate of 15.1%. Australia's Remote Patient Monitoring market is poised for substantial expansion, driven by an aging demographic, increasing prevalence of chronic diseases, and government initiatives promoting digital health adoption.

Australia Remote Patient Monitoring (RPM) Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Remote Patient Monitoring (RPM) Market Trends and Insights

  • This expansion reflects Australia's increasing adoption of digital health technologies and aging population demographics driving demand for continuous patient monitoring solutions.
  • Australia is positioning itself as a leader in telehealth integration within the Asia Pacific region, supported by government healthcare initiatives and private sector investment in connected care platforms. The Australian RPM market benefits from strong healthcare infrastructure, regulatory support, and rising chronic disease prevalence.
  • Australia's healthcare system is increasingly embracing remote monitoring to improve patient outcomes while reducing hospital readmissions and operational costs.
  • Between 2026 and 2031, Australia is expected to see accelerated deployment of wearable devices, cloud-based monitoring platforms, and AI-driven analytics across both urban and regional healthcare settings. Australia's competitive advantage stems from its tech-savvy population, favorable reimbursement policies, and collaboration between public health authorities and private providers.
  • The market in Australia is anticipated to attract significant investment from both domestic and international RPM vendors seeking to establish regional hubs for Asia Pacific expansion..

Key Market Statistics

  • CAGR (2026-2031) 15.1% CAGR
  • Market Size, 2026 ~USD 404.8 Million
  • Forecast, 2031 ~USD 816.1 Million
  • Country Australia

Australia Remote Patient Monitoring (RPM) Market Overview

Strong Market Valuation :

Australia's RPM market is valued at $404.8 million in 2026, demonstrating significant investment in digital health infrastructure and patient monitoring technologies across the nation.

Accelerated Growth Trajectory :

With a CAGR of 15.1% through 2031, Australia's RPM market is growing faster than the global average of 12.8%, reflecting strong local adoption and government support for telehealth initiatives.

Aging Population Driver :

Australia's demographic shift toward an older population is creating sustained demand for continuous patient monitoring solutions, particularly for chronic disease management and preventive care.

Telehealth Leadership Position :

Australia is establishing itself as a regional leader in integrating telehealth and RPM technologies, supported by favorable regulatory frameworks and healthcare system modernization efforts.

Australia Remote Patient Monitoring (RPM) Market Dynamics

  • The projected growth from $404.8 million in 2026 to $816.1 million by 2031 reflects strong healthcare sector investment and consumer acceptance of remote monitoring technologies. Key growth catalysts include enhanced Medicare reimbursement policies for telehealth services, integration with Australia's existing healthcare infrastructure, and rising demand from both public and private healthcare providers.
  • The market will benefit from technological advancements in wearable devices, cloud-based platforms, and AI-driven analytics, positioning Australia as a competitive hub for RPM innovation in the Asia-Pacific region..

Related Ecosystem

Cardiovascular Devices

Top Technologies
    Top Companies

      Diagnostic Imaging

      Top Technologies
        Top Companies

          Healthcare It

          Top Technologies
            Top Companies

              Key Takeaways

              • Australia's RPM market will double from $404.8M (2026) to $816.1M (2031), representing a 15.1% CAGR.
              • Australia's aging population and chronic disease burden are primary drivers of RPM adoption across public and private healthcare sectors.
              • Australia leads Asia Pacific in digital health infrastructure, positioning the country as a regional innovation hub for remote monitoring technologies.
              • Government reimbursement policies and private sector partnerships in Australia are accelerating RPM deployment and vendor market entry.

              Remote Patient Monitoring (RPM) Market Report Scope

              Report Metric Details
              Base Year 2026
              Fastest Growing Segment SYNCHRONOUS (Transmission Type)
              Forecast Period 2026–2031
              Growth Rate CAGR of 12.8% from 2026 to 2031
              Largest Segment HEALTHCARE PROVIDERS (End User)
              Market Size Base Year (Billions) ~USD 36.32 (2026)
              Revenue Forecast (Billions) ~USD 66.33 (2031)
              Segments Covered Component, Function, Type, Deployment Model, Transmission Type, Indication, End User, Deployment Type

              Australia Remote Patient Monitoring (RPM) Market Report Segmentation

              8 segment dimensions are covered across the global market.

              By Component

              • Devices
              • Services
              • Software

              By Function

              • Blood Glucose Monitoring
              • Cardiac Monitoring
              • Fetal & Neonatal Monitoring
              • Multiparameter Monitoring
              • Neurological Monitoring
              • Other Monitoring Devices
              • Pulse Oximeters
              • Respiratory Monitoring
              • Thermometers
              • Weight Monitoring

              By Type

              • Ambulatory Surgical Centers, Ambulatory Care Centers, And Other Outpatient Settings
              • Handheld & Portable
              • Handheld & Portable Devices
              • Home Healthcare
              • Hospitals
              • Implantable
              • Implantable Devices
              • Long-Term Care & Assisted Living Facilities
              • Other Healthcare Providers
              • Others (Stationary Devices And Others)
              • Others (Stationary Devices, And Others)
              • Wearable
              • Wearable Devices

              By Deployment Model

              • Cloud-Based Model
              • On-Premise Model

              By Transmission Type

              • Asynchronous
              • Synchronous

              By Indication

              • Cardiology
              • Diabetes
              • Mental Health
              • Neurology
              • Oncology
              • Other Indications
              • Respiratory Disorders
              • Sleep Disorders
              • Wellness Improvement

              By End User

              • Healthcare Payers
              • Healthcare Providers
              • Medtech Companies
              • Other End Users
              • Patients
              • Pharmaceutical & Biotechnology Companies

              By Deployment Type

              • Cloud-Based
              • On-Premises

              AUSTRALIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031

              Segment20242025202620272028202920302031CAGR (%)
              HEALTHCARE PAYERS59.469.681.294.3109125.7144.4165.315.3
              HEALTHCARE PROVIDERS134.1156.8182.3211243.4279.7320.3365.814.9
              MEDTECH COMPANIES14.516.819.522.425.729.433.538.114.4
              OTHER END USERS6.47.58.69.811.212.714.316.213.5
              PATIENTS5969.481.294.5109.7126.8146.1167.815.6
              PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES23.827.73236.942.448.655.46314.5
              TOTAL297.2347.8404.8469541.4622.8714816.115.1

              Target Audience

              • Healthcare Providers & Hospital Networks : Australian hospitals and clinics need market intelligence to implement RPM solutions, optimize patient outcomes, and align with government digital health mandates and reimbursement policies.
              • Medical Device & Software Companies : RPM technology vendors require Australia-specific market data to develop localized products, navigate regulatory pathways, and identify distribution and partnership opportunities.
              • Private Equity & Investment Firms : Investors evaluating healthcare technology opportunities in Australia need detailed market sizing, growth projections, and competitive analysis to make informed funding decisions.
              • Government & Health Policy Makers : Australian health authorities and policymakers require market insights to design effective digital health strategies, allocate resources, and evaluate RPM program effectiveness.
              • Insurance & Aged Care Providers : Insurers and aged care operators need RPM market data to assess cost-benefit opportunities, improve member health outcomes, and develop innovative care delivery models.

              Key Companies in the Australia Remote Patient Monitoring (RPM) Market

              CompanyHQOwnershipStrongest segments
              KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health,
              MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring),
              GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
              ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
              ORACLEUnited StatesPublic CompanyCloud Applications (Fusion ERP/EPM/SCM/HCM, NetSuite, CX, Health),Database and Infrastructure Technologies (Oracle DB, MySQL, Autonomous, Middleware, Java),Cloud Infrastructure (Compute, Storage, Networking, AI/ML, Digital Assistant, Blockchain),
              BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, LAAC, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
              NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, and resuscitation devices,
              SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
              BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV solutions, infusion, parenteral nutrition, renal and related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),

              KONINKLIJKE PHILIPS N.V.

              Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 64,317 employees, operating across healthcare and technology sectors.

              MEDTRONIC

              Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees, providing medical devices and healthcare solutions.

              GE HEALTHCARE

              GE Healthcare is a public healthcare company established in 2022 in the United States with 54,000 employees, offering medical imaging and healthcare technology.

              ABBOTT

              Abbott is a public healthcare and diagnostics company founded in 1888 in the United States with 115,000 employees.

              ORACLE

              Oracle is a public software and cloud computing company founded in 1977 in the United States with 141,000 employees.

              BOSTON SCIENTIFIC CORPORATION

              Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.

              NIHON KOHDEN CORPORATION

              Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical equipment and healthcare technology.

              SIEMENS HEALTHINEERS AG

              Siemens Healthineers AG is a German public healthcare company founded in 1896 with 72,369 employees, providing medical imaging and diagnostic solutions.

              BAXTER

              Baxter is a public healthcare company founded in 1931 in the United States with 37,500 employees, specializing in medical devices and pharmaceuticals.

              Reasons to Buy this Report

              • Market-Specific Growth Data : Access detailed forecasts and historical data exclusive to Australia's RPM market, enabling accurate business planning and investment decisions tailored to local market conditions.
              • Competitive Landscape Intelligence : Understand Australia-specific competitive dynamics, key players, and market positioning strategies to identify opportunities and threats within the local healthcare technology ecosystem.
              • Regulatory & Reimbursement Insights : Gain comprehensive analysis of Australian healthcare policies, Medicare reimbursement frameworks, and regulatory requirements affecting RPM adoption and market expansion.
              • Demographic & Clinical Trends : Leverage Australia-specific demographic data and disease prevalence patterns to identify high-opportunity patient segments and develop targeted market entry strategies.
              • Strategic Partnership Opportunities : Identify potential collaborators, healthcare providers, and technology partners within Australia's RPM ecosystem to accelerate market penetration and business growth.

              Frequently asked questions

              What is the projected market size of RPM in Australia by 2031?

              Australia's RPM market is forecast to reach $816.1 million by 2031, up from $404.8 million in 2026, representing a 15.1% compound annual growth rate.

              What are the main drivers of RPM growth in Australia?

              Key drivers include Australia's aging demographic, rising prevalence of chronic diseases, government digital health initiatives, favorable reimbursement policies, and increasing adoption of wearable and cloud-based monitoring technologies.

              How does Australia's RPM market compare to the global market?

              Australia's RPM market is growing at 15.1% CAGR, outpacing the global average of 12.8%, reflecting stronger digital health adoption and supportive regulatory frameworks in the country.

              Which healthcare segments in Australia are driving RPM adoption?

              Australia's RPM adoption is driven by chronic disease management programs, aged care facilities, cardiology and diabetes monitoring, mental health services, and post-acute care settings across both public and private sectors.

              What role does government policy play in Australia's RPM market expansion?

              Australia's government supports RPM through telehealth reimbursement schemes, digital health infrastructure investments, and regulatory frameworks that encourage remote monitoring adoption in primary and secondary care settings.

              RESEARCH METHODOLOGY

              The study involved major activities in estimating the current market size for the remote patient monitoring market.

              Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.  

              Secondary Research

              In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

              Primary Research

              Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

              BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS

              Remote Patient Monitoring Market 
 Size, and Share

              Note 1: Others include sales managers, marketing managers, and product managers.

              Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

              To know about the assumptions considered for the study, download the pdf brochure

              Market Size Estimation

              Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

               The research methodology used to estimate the market size includes the following:

              Remote Patient Monitoring Market Top Down and Bottom Up Approach

              Data Triangulation

              After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.

              Market Definition

              The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.

              Key Stakeholders

              • RPM Equipment and devices Manufacturers
              • Suppliers and Distributors of RPM Equipment
              • RPM software provider
              • Healthcare IT Service Providers
              • Healthcare Insurance Companies/Payers
              • Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
              • Venture Capitalists
              • Government Bodies/Regulatory Bodies
              • Corporate Entities
              • Accountable Care Organizations
              • RPM Resource Centers
              • Research and Consulting Firms
              • Medical Research Institutes
              • Clinical Departments

              Report Objectives

              • To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
              • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
              • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
              • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
              • To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
              • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
              • To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.

              Available customizations:

              With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

              • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
              • Geographic Analysis:  Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries

               

              Get the Full Remote Patient Monitoring (RPM) Market Report

              Full forecast, segment splits, and company analysis for all Remote Patient Monitoring (RPM) Market.

              Need a Tailored Report?

              Customize this report to your needs

              Get 10% FREE Customization

              Customize This Report
              Fact checked
              DMCA.com Protection Status